Indeed, the effect of anti-CD20 antibody treatment on GM pathology was investigated in human myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (huMOG-EAE) mice by means of serial brain volumetric MRI scans performed at baseline, 1 and 5 weeks post-huMOG-EAE induction and anti-CD20 treatment [17]. Here, MOG is linked to experimental autoimmune encephalomyelitis.